This grant, offered by the Department of Defense (DoD) Neurofibromatosis Research Program (NFRP), aims to decrease the clinical impact of Neurofibromatosis (NF) by supporting innovative, high-impact, high-risk, and potentially groundbreaking research concepts. It seeks to foster new directions, address neglected issues, and promote multidisciplinary collaborations, encouraging the next generation of NF investigators. The award supports initial explorations that can provide the scientific rationale for new hypotheses, including serendipitous observations. Key areas of emphasis include cognitive and social dysfunction, drug discovery for treatment, understanding tumor heterogeneity, manifestations post-adolescence, novel disease markers like imaging and proteomics, and pain management in NF settings. The program encourages translational and clinical studies to move promising ideas from bench to bedside.
Opportunity ID: 233093
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-NFRP-EHDA |
| Funding Opportunity Title: | DoD Neurofibromatosis Exploration Hypothesis Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 03, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 11, 2013 |
| Current Closing Date for Applications: | Jul 11, 2013 |
| Archive Date: | Aug 10, 2013 |
| Estimated Total Program Funding: | $640,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis. Areas of Emphasis: The FY13 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the following Areas of Emphasis: Cognitive and social dysfunction in the setting of NF; Drug discovery for the treatment of NF; Heterogeneity of neurofibromas and other NF-related tumors using genomics, epigenetics, systems biology, or other similar approaches; Manifestations of NF post-adolescence; Novel disease markers such as imaging and proteomics of NF; Pain in the setting of NF. The Exploration Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the NF research field. The proposed research project should provide initial principles of an innovative question/concept and results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based. This award is designed to provide investigators with the opportunity to pursue serendipitous observations. The presentation of preliminary or published data is encouraged, but not required. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative and how the concept is novel. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 233093 Full Announcement-1 -> nfrp_fy13 ehda pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00176372 | May 03, 2013 | Jul 11, 2013 | View |
Package 1
Mandatory forms
233093 RR_SF424_1_2-1.2.pdf
233093 PerformanceSite_1_4-1.4.pdf
233093 RR_Budget-1.1.pdf
233093 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
233093 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
